Record and track on the go! Our customizable mobile app lets you track your injections instantly and efficiently with your iPhone®, iPod touch®, iPad®, or Android™ device.

Share, Send, or Save logo

Relapsing MS Symptoms

Symptoms you may experience with RRMS and CIS

The symptoms of relapsing MS —RRMS and CIS— are unpredictable and vary from one person to another.1 The symptoms you may experience vary, depending on the location and the extent of the damage in your central nervous system (CNS).2 It is not likely that you will experience all of the symptoms listed.

You may find that you experience some of the symptoms at different times during the course of relapsing MS. The available disease-modifying relapsing MS therapies are not intended to treat the symptoms that accompany relapsing MS. Many of these symptoms can be managed with specific drug therapies, rehabilitation, and lifestyle strategies.1-3

The most common relapsing MS symptoms are:1

  • Weakness
  • Fatigue, lack of energy
  • Numbness
  • Tingling sensations
  • Walking, balance, and coordination problems
  • Dizziness
  • Blurred vision
  • Slurred speech
  • Bladder problems
  • Bowel problems
  • Depression
  • Memory loss, difficulty concentrating, and/or difficulty solving problems

Possible risk factors for multiple sclerosis (MS)

Based on the worldwide distribution of MS, scientists have identified factors that may provide clues to the possible causes of MS. These include the following:

Gender: Women are 2 to 3 times more likely to have MS than men.4

Genetics: MS is not directly inherited; however, the risk of getting MS rises in people who have a close relative (parent, sibling, or child) with MS.4

Age: Most people are diagnosed with MS between the ages of 20 and 50.4

Ethnic background: MS affects most ethnic groups, but it is more common among people of northern European ancestry.4

Geography: MS occurs more frequently in people who live farther from the equator; it occurs less commonly in areas closer to the equator.4

You are not alone. Worldwide, MS may affect more than 2.3 million individuals.4

back to top


Make the move to 3-times-a-week COPAXONE® 40 mg.